| Date | Time | Source | Headline | Symbol | Company |
| 06/02/2008 | 10:20AM | PR Newswire (US) | BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR | NASDAQ:GILD | Gilead Sciences Inc |
| 05/30/2008 | 4:59PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/29/2008 | 3:33PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/29/2008 | 3:15PM | Business Wire | Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension | NASDAQ:GILD | Gilead Sciences Inc |
| 05/29/2008 | 7:30AM | Business Wire | Data from Pivotal Phase III Studies of Gilead's Letairis(R) (ambrisentan) for Pulmonary Arterial Hypertension (WHO Group 1) in P | NASDAQ:GILD | Gilead Sciences Inc |
| 05/27/2008 | 1:45PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/27/2008 | 1:40PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/27/2008 | 1:37PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/22/2008 | 5:31PM | Edgar (US Regulatory) | Gilead Sciences Inc - Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/22/2008 | 3:30PM | Business Wire | Gilead Sciences' Chairman and Chief Executive Officer Establishes Rule 10b5-1 Stock Trading Plan | NASDAQ:GILD | Gilead Sciences Inc |
| 05/22/2008 | 11:31AM | PR Newswire (US) | Seven Summits Research Releases Comments on F, MON, GILD, ISRG, and NTES | NASDAQ:GILD | Gilead Sciences Inc |
| 05/21/2008 | 1:13PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/20/2008 | 5:05PM | Business Wire | U.S. Patent Office Confirms First of Four Viread(R) Patents | NASDAQ:GILD | Gilead Sciences Inc |
| 05/20/2008 | 10:45AM | Business Wire | Gilead Announces New Letairis(R) (Ambrisentan) Data for the Treatment of Patients With Pulmonary Arterial Hypertension (WHO Grou | NASDAQ:GILD | Gilead Sciences Inc |
| 05/14/2008 | 4:15PM | Business Wire | Gilead Sciences to Present at the 2008 Citi Investment Research Global Healthcare Conference on Wednesday, May 21 | NASDAQ:GILD | Gilead Sciences Inc |
| 05/14/2008 | 6:05AM | Edgar (US Regulatory) | Gilead Sciences Inc - Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/13/2008 | 5:17PM | Business Wire | Gilead Sciences' Board Member Establishes Rule 10b5-1 Stock Trading Plan | NASDAQ:GILD | Gilead Sciences Inc |
| 05/09/2008 | 4:38PM | Edgar (US Regulatory) | Gilead Sciences Inc - Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/09/2008 | 4:35PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/09/2008 | 4:34PM | Edgar (US Regulatory) | Gilead Sciences Inc - Initial Statement of Beneficial Ownership (3) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/09/2008 | 3:16PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/07/2008 | 4:15PM | Business Wire | Gilead Appoints John C. Martin as Chairman of Board of Directors; Names John F. Milligan President | NASDAQ:GILD | Gilead Sciences Inc |
| 05/02/2008 | 5:58PM | Edgar (US Regulatory) | Gilead Sciences Inc - Quarterly Report (10-Q) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/02/2008 | 5:15PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/02/2008 | 5:15PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/02/2008 | 5:15PM | Edgar (US Regulatory) | Gilead Sciences Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 05/01/2008 | 4:05PM | Business Wire | Gilead Initiates Letairis(R) (ambrisentan) Phase IV Program | NASDAQ:GILD | Gilead Sciences Inc |
| 05/01/2008 | 10:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on GOOG, ORCL, HD, M, and GILD | NASDAQ:GILD | Gilead Sciences Inc |
| 04/25/2008 | 4:35PM | Edgar (US Regulatory) | Gilead Sciences Inc - Prospectus filed pursuant to Rule 424(b)(7) (424B7) | NASDAQ:GILD | Gilead Sciences Inc |
| 04/25/2008 | 9:22AM | Business Wire | European Commission Approves Viread(R) for Chronic Hepatitis B | NASDAQ:GILD | Gilead Sciences Inc |